ECO Animal Health Group plc (AIM:EAH)

London flag London · Delayed Price · Currency is GBP · Price in GBX
60.00
-1.45 (-2.42%)
Jul 8, 2025, 11:23 AM GMT+1
-53.13%
Market Cap 40.66M
Revenue (ttm) 84.60M
Net Income (ttm) 658.00K
Shares Out 67.76M
EPS (ttm) 0.01
PE Ratio 62.49
Forward PE 33.33
Dividend n/a
Ex-Dividend Date n/a
Volume 1,779
Average Volume 56,394
Open 58.55
Previous Close 60.00
Day's Range 58.55 - 60.00
52-Week Range 50.00 - 133.70
Beta 0.03
RSI 37.91
Earnings Date Jul 10, 2025

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline... [Read more]

Sector Healthcare
Founded 1972
Employees 227
Stock Exchange London Stock Exchange AIM
Ticker Symbol EAH
Full Company Profile

Financial Performance

In 2023, ECO Animal Health Group's revenue was 89.42 million, an increase of 4.82% compared to the previous year's 85.31 million. Earnings were 1.05 million, an increase of 3.97%.

Financial Statements

News

There is no news available yet.